123 results on '"WINDER, ROBERT"'
Search Results
2. Cancer therapy a new chapter: could we be about to witness a new chapter in the fight against cancer? Robert Winder investigates a new wave of therapeutics
3. Demand wants supply; as oil prices continue to rise, Robert Winder looks at how BASF is managing its energy usage
4. Biotech pipeline fit to burst: as record numbers of biotech drugs are approved, can the biopharmaceutical manufacturing sector cope with an overflowing pipeline?
5. Testing times: AstraZeneca's development director John Patterson talks to Robert Winder about some of the challenges facing the drug discovery and development industry
6. Political science: on the eve of the UK government's general election, Robert Winder reports on the Conservative, Liberal Democrat and Labour policies on science
7. Finnish connection: despite emerging challenges, Finland's chemicals industry is growing with promise
8. The molecular shuffle: molecular evolution technologies can reduce the cost of goods, deliver intellectual property benefits, and reduce or obviate the need for capital investment
9. A light at the end of the tunnel: fine chemicals sector has been through a torrid time but, despite no sign of an upturn, analysts are sure the sector is ripe with potential. (includes related article)
10. Bring it back on track: the UK chemicals industry is research-intensive and depends on the development of new products to drive growth. Robert Winder explores how it can increase productivity
11. Plant-made therapeutics: Robert Winder examines how plants could be used to produce a new generation of therapeutics and pharmaceuticals
12. Global health under threat: biotech has a responsibility to address the dire need for improved healthcare in developing nations--that was the message at Bio2003
13. Hydrogen fuels: it may constitute only 0.00005% of the earth's atmosphere, but hydrogen is increasingly being touted as the automobile fuel of the future. (Energy)
14. Welcome to the Informex USA 2007: Robert Winder reports from San Francisco on the mood at Informex USA 2007
15. Pure enzymes: biocatalysts could be the answer to the process chemist's chiral conundrum, according to Robert Winder, who reports on developments in Germany
16. BIO 2006: Robert Winder reports from BIO 2006 in Chicago--the biggest ever
17. Bridging the gap: while the UK's biopharmaceutical sector is thriving, it is not capturing its full value. Robert Winder reports on bioProcessUK--an initiative addressing industry's major challenges
18. Herbicidal tendencies: the British Crop Protection Council annual conference showcased a number of new agrochemicals. Robert Winder reports on the latest announcements and developments
19. Who's making the medicine? Robert Winder examines the problems involved in raising funding for biotech companies
20. Cell culture grows capacity; capacity expansions address the 'crunch' for biopharmaceutical manufacturing. Robert Winder reports on the increases being introduced to meet growing demand
21. A new wave of consolidation: is recent activity in the fine chemicals sector the beginning of a new round of consolidation
22. Sandblasting blood clots using nanobubbles
23. Banking on biotech: Serono is expanding its protein biotech plant capacity 10-fold, because future drugs will be delivered at high doses
24. ChemSpec success: ChemSpec 2004 attracted a record crowd to Amsterdam, where the annual trade show for the fine and speciality chemicals industry had much to offer them
25. Wooed down the aisles: public perception of biotechnology was a big talking point at BIO 2004
26. Market trends: despite challenges, the speciality chemicals sector is looking up, with innovation in Europe and the US, and manufacturing in lower-cost centres
27. Number crunching: Robert Winder reports on the laboratory information management system's rise from a mere quality assurance and control tool to a total R&D solution
28. Biotech's firm footing: with life sciences eclipsing software as the premier destination for venture capital funding, Robert Winder reports on the changing financial foundations of biotechnology
29. Analytica's appeal: record attendance figures are expected for Analytica 2004 in May
30. Biotech promises a bright future; industrial biotechnology can help create sustainable products, using crops rather than fossil fuels as its raw materials
31. True clusters: clustering can offer benefits to biotech companies
32. Upward trends: the global petrochemicals sector is having a difficult time. Raw materials costs are high and product demand is low
33. Pittcon comes to the Windy City: Chicago is set to host this year's Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, to be held from 7-12 March
34. Informex: a hive of activity: Robert Winder continues the round-up of the stories making the news at the 20th Informex trade show in Las Vegas
35. Showtime at informex: Robert Winder reports on the fine chemical custom manufacturing industry's news from the 20th Informex trade show, held this year in Las Vegas
36. Time to take stock: the stock markets try to value the future earnings capacities of companies. Find out what some of the most respected names think will be happening in 2004
37. Look to the long term: Robert Winder examines the outlook for the global chemicals industry in 2004, where the emphasis is on long-term strategies and a focus on emerging technologies
38. Consolidation key to growth: the speciality chemicals sector is ripe for mergers and acquisitions when the downturn ends
39. Stakes are high at end 2003: 2003 proved to be a mixed year for the business of chemistry in Europe and around the world. Robert Winder rounds up some of the key economic developments
40. Together we're stronger: biotech-pharma partnerships are the key to continuing drug innovation, according to the BioPartnering Europe conference in London
41. Innovation on show: despite companies in the fine chemicals sector feeling the squeeze, the theme of this year's CPhI was investment, innovation and expansion
42. Electronic screening: researchers at Merck KgaA have been nominated for Germany's Future prize 2003. Robert Winder looks at the liquid crystal display technology that has won it the nomination
43. Higher temperature HPLC equals high performance: a temperature controller such as Selerity's Polaratherm can improve high-pressure liquid chromatography
44. Petchems feel the heat: soaring gas prices have sparked a chain reaction, hitting the US plastics and petrochemicals producers and damaging confidence throughout the industry
45. OFBR causes a stir: Robert Winder looks at how a continuous oscillatory flow baffled reactor can maximise yields and provide a more efficient and compact method for mixing reactants than batch processes
46. Alcoholic fuel: Ethanol and a Nafion membrane is all that is needed to produce energy by biocatalysis. Robert Winder reports on a technology that overcomes most biofuel cell setbacks
47. Double-edged sword: Ian Stark and Nick Hyde talk to Robert Winder about the Dow Chemical's speciality chemicals and biopharmaceuticals offerings, since it acquired Union Carbide and Ascot
48. Chiral catalysis: Robert Winder examines catalyst licences and ligand libraries, in the search for active ingredients and intermediates
49. Stimulating clusters: countries are investing billions of dollars in biotech--the key priority sector on which all nations' economic success depends. (Biotech)
50. Bio-based economies: alongside global healthcare, industrial biotechnology attracted considerable interest at Bio2003 in June, Washington DC. (Bio2003)(Cover Story)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.